My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 457

    1.

    Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy.

    Gahl WA, Balog JZ, Kleta R.

    Ann Intern Med. 2007 Aug 21;147(4):242-50.PMID: 17709758 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy.

    Sonies BC, Almajid P, Kleta R, Bernardini I, Gahl WA.

    Medicine (Baltimore). 2005 May;84(3):137-46.PMID: 15879904 [PubMed - indexed for MEDLINE]Related articles

    3.

    Follow-up and treatment of adults with cystinosis in the Netherlands.

    Geelen JM, Monnens LA, Levtchenko EN.

    Nephrol Dial Transplant. 2002 Oct;17(10):1766-70.PMID: 12270982 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Swallowing dysfunction in nephropathic cystinosis.

    Sonies BC, Ekman EF, Andersson HC, Adamson MD, Kaler SG, Markello TC, Gahl WA.

    N Engl J Med. 1990 Aug 30;323(9):565-70.PMID: 2381441 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pulmonary dysfunction in adults with nephropathic cystinosis.

    Anikster Y, Lacbawan F, Brantly M, Gochuico BL, Avila NA, Travis W, Gahl WA.

    Chest. 2001 Feb;119(2):394-401.PMID: 11171714 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy.

    Tsilou ET, Rubin BI, Reed G, Caruso RC, Iwata F, Balog J, Gahl WA, Kaiser-Kupfer MI.

    Ophthalmology. 2006 Jun;113(6):1002-9. Epub 2006 Apr 17.PMID: 16603246 [PubMed - indexed for MEDLINE]Related articles

    7.

    NIH conference. Cystinosis: progress in a prototypic disease.

    Gahl WA, Thoene JG, Schneider JA, O'Regan S, Kaiser-Kupfer MI, Kuwabara T.

    Ann Intern Med. 1988 Oct 1;109(7):557-69. Review.PMID: 3048161 [PubMed - indexed for MEDLINE]Related articles

    8.

    Nephropathic cystinosis: late complications of a multisystemic disease.

    Nesterova G, Gahl W.

    Pediatr Nephrol. 2008 Jun;23(6):863-78. Review.PMID: 18008091 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pharmacological treatment of nephropathic cystinosis with cysteamine.

    Kleta R, Gahl WA.

    Expert Opin Pharmacother. 2004 Nov;5(11):2255-62. Review.PMID: 15500372 [PubMed - indexed for MEDLINE]Related articles

    10.

    Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.

    Gahl WA, Kuehl EM, Iwata F, Lindblad A, Kaiser-Kupfer MI.

    Mol Genet Metab. 2000 Sep-Oct;71(1-2):100-20. Review.PMID: 11001803 [PubMed - indexed for MEDLINE]Related articles

    11.

    Evolution of ocular manifestations in nephropathic cystinosis: a long-term study of a population treated with cysteamine.

    Dureau P, Broyer M, Dufier JL.

    J Pediatr Ophthalmol Strabismus. 2003 May-Jun;40(3):142-6.PMID: 12795432 [PubMed - indexed for MEDLINE]Related articles

    12.

    Early oral cysteamine therapy for nephropathic cystinosis.

    Gahl WA.

    Eur J Pediatr. 2003 Dec;162 Suppl 1:S38-41. Epub 2003 Nov 11. Review.PMID: 14610675 [PubMed - indexed for MEDLINE]Related articles

    13.

    Classic nephropathic cystinosis as an adult disease.

    Theodoropoulos DS, Krasnewich D, Kaiser-Kupfer MI, Gahl WA.

    JAMA. 1993 Nov 10;270(18):2200-4.PMID: 8411603 [PubMed - indexed for MEDLINE]Related articles

    14.

    Parenchymal organ cystine depletion with long-term cysteamine therapy.

    Gahl WA, Charnas L, Markello TC, Bernardini I, Ishak KG, Dalakas MC.

    Biochem Med Metab Biol. 1992 Dec;48(3):275-85.PMID: 1476793 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis.

    Kimonis VE, Troendle J, Rose SR, Yang ML, Markello TC, Gahl WA.

    J Clin Endocrinol Metab. 1995 Nov;80(11):3257-61.PMID: 7593434 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic Cystinosis.

    Wühl E, Haffner D, Gretz N, Offner G, van't Hoff WG, Broyer M, Mehls O.

    Pediatr Res. 1998 Apr;43(4 Pt 1):484-8.PMID: 9545002 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intravenous delivery of cysteamine for the treatment of cystinosis: association with hepatotoxicity.

    Bendel-Stenzel MR, Steinke J, Dohil R, Kim Y.

    Pediatr Nephrol. 2008 Feb;23(2):311-5. Epub 2007 Aug 1.PMID: 17668247 [PubMed - indexed for MEDLINE]Related articles

    18.

    Nephropathic cystinosis: effect of long-term cysteamine therapy.

    Proesmans W, Baten E, Hoogmartens J, Bruyneel P.

    Clin Nephrol. 1987 Jun;27(6):309-12.PMID: 3608256 [PubMed - indexed for MEDLINE]Related articles

    19.

    Improved renal function in children with cystinosis treated with cysteamine.

    Markello TC, Bernardini IM, Gahl WA.

    N Engl J Med. 1993 Apr 22;328(16):1157-62.PMID: 8455682 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine.

    Gahl WA, Schneider JA, Schulman JD, Thoene JG, Reed GF.

    Pediatr Nephrol. 1990 Mar;4(2):129-35.PMID: 2397178 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity